Estimated Risk News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The Rise of Obesity in the US: Recognizing Gastrointestinal and Hepatic Comorbidities

Obesity rates in the US have skyrocketed, and so has the prevalence of several comorbid gastrointestinal and hepatic diseases - not all patients know their risks or have the financial means to take preventative measures.

United statesRoberto simons linaresBincy abrahamChamil codipillyIntj environ res public healthNutrition examinationMount sinai health systemHealth consequencesFondren inflammatory bowel disease programUs centers for diseaseUnderwood centerNational healthObesity allianceWorld health organizationCenters for diseaseNutrition examination survey

Risk for dementia reduced in association with antihypertensive use

Risk for dementia reduced in association with antihypertensive use
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

New south walesMatthewj lennonUniversity of new south walesInternational consortiumCohort studiesBlood pressureEstimated riskLate life

Curcumin nanosystems could be powerful COVID-19 therapeutics

Curcumin nanosystems could be powerful COVID-19 therapeutics With new variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerging, the coronavirus disease 2019 (COVID-19) pandemic is far from over. While the global vaccine rollout has moved at an impressive speed, the search for new safe, effective, and targeted therapies is still on. Now, a new study in Biomedicine and Pharmacotherapy reviews the potential for curcumin, a natural alkaloid derived from turmeric, and nanosystems to treat COVID-19. The need for therapeutics COVID-19 is caused by infection with the novel SARS-CoV-2 pathogen, which engages and enters host cells through its spike protein. At present, there are more than 138.3 million documented cases globally, with the death toll nearing three million.

Liji thomasEstimated riskAir travel systemSystemic reviewImage creditCoronavirus disease covid 19Ars cov 2N vivoEvere acute respiratoryEvere acute respiratory syndromeSpike proteinஅேக பயணம் அமைப்புமுறையான விமர்சனம்படம் கடன்

Researchers assess SARS-CoV-2 transmission risk during air travel

Researchers assess SARS-CoV-2 transmission risk during air travel A team of scientists from the United States recently conducted a meta-analysis to estimate the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection during air travel. The findings reveal that even with SARS-CoV-2-infected persons onboard, the risk of viral transmission is low inside an aircraft. The study is currently available on the Background As of April 15, 2021, globally, there have been 136 million confirmed cases of coronavirus disease 2019 (COVID-19), including 2.9 million deaths, registered to the World Health Organization (WHO). At the initial phase of the pandemic, strict control measures applied to control the viral transmission have severely impacted the socioeconomic status of many countries globally. Because of national and international travel restrictions, the aviation industries have faced an almost 95% drop in passenger numbers during the initial phase of the pandemic.

United statesHan iRepublic ofCity ofUnited kingdomSanchari sinha duttaThanakornp shutterstockWorld health organizationEstimated riskAir travel systemSystemic reviewImage creditஒன்றுபட்டது மாநிலங்களில்ஹான் நான்குடியரசு ஆஃப்நகரம் ஆஃப்